About Us
Founded in 1944, the American Committee for the Weizmann Institute of Science develops philanthropic support for the Weizmann Institute in Israel, and advances its mission of science for the benefit of humanity.
Mar 09, 2020...
JERUSALEM, Feb. 24 (Xinhua)— Israeli scientists found that short-term acute inflammation in the mother's body during pregnancy can cause autism to the embryo, said Weizmann Institute of Science (WIS) in central Israel on Monday.
Signs of autism usually appear around two or three years old, but it is considered a neurodevelopmental disease, which suggests that changes could already be “brewing” in the embryonic brain.
Jan 28, 2020... Immunotherapies, which harness the immune system to fight disease, are revolutionizing treatments for many types of cancer. Having made significant breakthroughs in the field, Weizmann Institute of Science researchers are now exploring ways to apply immunotherapy to conditions other than cancer, including neurodegenerative diseases like Alzheimer’s. Prof. Ido Amit of the Department of Immunology is advancing this research by developing sophisticated tools and technologies to investigate the immune system’s role in neurodegenerative diseases.
Jan 05, 2020...
If visions of sugarplums are still dancing in your head after the holidays, it’s time to get real. We all know what happens when we overindulge in Hanukkah sufganiyot or Christmas fruitcake, and it’s not a pretty picture.
After one too many cups of eggnog or a mountain of sour cream and latkes, we resolve to slim down in the new year. Again.
How can you make your weight-loss plan more successful this time around? We reviewed Israeli research and found these suggestions for effective dieting.
May 11, 2020... Researchers in Israel have succeeded in determining the biological processes that characterize seriously ill COVID-19 patients, as compared to those who are only mildly affected. The researchers, headed by Prof. Ido Amit from the Department of Immunology at the Weizmann Institute of Science in Rehovot, examined the differences between those who were seriously ill and lightly ill. They based their analysis partly on the virus’ activity at the single cell level.
May 14, 2020...
Throughout the COVID-19 outbreak, one of the greatest mysteries to confound researchers has been figuring out why the disease leaves some people almost completely unharmed, while others suffer serious conditions and die.
The answer, according to Israeli scientists, is that lungs of the worst-affected patients become riddled with immune cells that exacerbate the pathogen’s impact instead of fighting it. In patients who are less affected by the disease, this doesn’t happen, says the team from the Weizmann Institute of Science.
May 17, 2020...
An immune system run amok may be responsible for some Covid-19 patients faring worse than others, suggests a new international study led by immunology researchers at Israel’s Weizmann Institute of Science.
Published in the journal Cell on May 7, “Host-viral infection maps reveal signatures of severe COVID-19 patients,” researchers in the lab of Prof. Ido Amit introduce Viral-Track, a computational method they have validated to systematically detect viruses from multiple models of infection.
Apr 06, 2020...
A comprehensive review of published studies on gut microbiota, immunity and arthritis suggests that having a microbial imbalance may precede the development of spondyloarthritides and osteoarthritis.
The review, which was published in Seminars in Arthritis and Rheumatism, suggests a close connection between an impaired microbiota, the immune system and inflammatory arthritis.
“In this review, we presented data supporting the idea that dysbiosis via a close, dynamic and tightly regulated cross talk with gut-associated lymphoid tissue, governs the development of inflammatory arthropathies, such as rheumatoid arthritis, spondyloarthritis and osteoarthritis. It became clear that unfavorable dysbiosis-mediated immune alterations precede the development of these disorders suggesting causal relationships in this link,” wrote authors Alexander Kalinkovich of the Weizmann Institute of Science in Israel, and Gregory Livshits of Tel Aviv University.
Apr 27, 2020... On May 2, 1986, while visiting my long-term colleague and friend Richard O’Reilly, the head of bone marrow transplantation at Memorial Sloan Kettering Cancer Center in New York, I received a strange phone call. It was from Richard Champlin, who worked at the Bone Marrow Transplant Center at UCLA. He tended to speak very fast, so it took me some time to understand from his over-excited voice that he was about to leave the next day for Moscow.
Apr 16, 2020... Immunologist Dr. Ziv Shulman is looking for antibodies to COVID by studying patients who have recovered from the virus. His work is “in a very exciting stage,” as he is now producing antibodies in the lab.
Apr 22, 2020... As he discusses in this video, Prof. Sarel Fleishman of the Department of Biomolecular Sciences is supporting multiple lines of coronavirus research at Weizmann – including his own.
©2022 American Committee for the Weizmann Institute of Science
FOR THE FOURTH CONSECUTIVE YEAR